The principal goals of this application are 1) to develop selective, potent analogues of lead anticancer beta-? lactams that are highly effective in vitro and in vivo and 2) to create an effective learning experience for the? minority students who participate in this research. The long-term goal is to identify one or more analogues for? clinical evaluation. A need exists for new and novel anticancer agents with high potency, efficacy against? malignant cell growth yet with reduced toxicity to non-cancerous cells. Toward this goal, studies of beta-lactams? as new chemotherapeutic agents would be very timely and useful.? A number of novel beta-lactams that have multicyclic aromatic groups have been synthesized. Some of them? have demonstrated promising anticancer activity in vitro. In some instances this activity exceeded that of a? well-known and clinically useful drug, cisplatin. In preliminary experiments one of these beta-lactams has shown? anticancer activity in vivo against ovarian and colon cancer cell lines to a moderate degree. In an early? search for the mechanism of action of these compounds, preliminary studies have demonstrated an? extremely active blockade of the G2/M checkpoint in cancer cell lines.? To identify the structural and mechanistic relationships and to more carefully identify selectivity of anticancer? activity, an extended series of carefully designed beta-lactams analogues, related to lead compounds will be? prepared. These include synthesis of racemic and optically active beta-lactams by Staudinger- and metal-mediated,? and enolate condensation reactions. As an alternative approach, synthesis of these beta-lactams? using domestic and automated microwave oven will also be performed. In vitro cytotoxicity will be utilized to? determine the relative activity of these analogues and logical structural-stereochemical based pathway? relationships will be explored to enhance their action. The ability of compounds to induce G2 cell cycle? blockade for tests of mechanistic targets and efficacy will be investigated. In addition, their activity against? DNA replication and induction of apoptosis will be studied. In a later aspect of the testing for the mechanism? of action, a selected gene arrays designed to examine key elements of apoptosis will be accomplished. The? same array will also be used to examine changes in genes known to be of importance in regulating the cell? cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
5S06GM008038-38
Application #
7676735
Study Section
Minority Programs Review Committee (MPRC)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
38
Fiscal Year
2008
Total Cost
$160,538
Indirect Cost
Name
University of Texas-Pan American
Department
Type
DUNS #
069444511
City
Edinburg
State
TX
Country
United States
Zip Code
78539
Jou, Jerwen (2011) Conscious and unconscious discriminations between true and false memories. Conscious Cogn 20:828-39
Ahmad, H; Tobola, A S; Silva, A et al. (1998) Glutathione S-transferase of goat lens: evidence for expression of only class mu isoenzymes. Curr Eye Res 17:1097-101
Farooqui, M Y; Ybarra, B; Piper, J et al. (1995) Effect of dosing vehicle on the toxicity and metabolism of unsaturated aliphatic nitriles. J Appl Toxicol 15:411-20
Montgomery, G T (1994) Headache characteristics among high school and university students. Headache 34:247-56
Farooqui, M Y; Ybarra, B; Piper, J (1993) Toxicokinetics of allynitrile in rats. Drug Metab Dispos 21:460-6
Farooqui, M Y; Ybarra, B; Piper, J (1993) Metabolism of allylnitrile to cyanide: in vitro studies. Res Commun Chem Pathol Pharmacol 81:355-68
Farooqui, M Y; Diaz, R G; Deleon, J H (1992) Methacrylonitrile: in vivo metabolism to cyanide in rats, mice, and gerbils. Drug Metab Dispos 20:156-60